Feedback / Questions
CT-0525 - CARISMA Therap
https://www.prnewswire.com/news-releases/carisma-therapeutics-announces-first-patient-dosed-in-phase-1-clinical-trial-of-ct-0525-a-novel-her2-targeting-car-monocyte-302146805.html
May 16, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next